Market Value1,679,836,000
Total Holdings68
File Date2021-02-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CALA / Calithera Biosciences, Inc. Call
NXTC / NextCure, Inc.
AMGN / Amgen Inc. Call
Nextcure, Inc / COMM (00653E112)
Nucana Biomed Ltd / Ordinary Shares (GBOOBYWYV)
Protagonist Therapeutics Inc / COMM (00744E106)
OVID / Ovid Therapeutics Inc.
GWP / GW Pharmaceuticals plc
SVRA / Savara Inc.
PDSB / PDS Biotechnology Corporation
OTIC / Otonomy Inc
ATHA / Athira Pharma, Inc.
AMGN / Amgen Inc.
ZGNX / Zogenix Inc
CCXI / ChemoCentryx Inc
PBYI / Puma Biotechnology, Inc.
MRNA / Moderna, Inc. Call
48283N114 / Kadmon Warrants Exp. 09/29/2022
US62857M1053 / MyoKardia, Inc.
FIXX / Homology Medicines, Inc.
US16706W1027 / Chiasma Inc
TCRR / Tcr2 Therapeutics Inc
KURA / Kura Oncology, Inc.
ACRS / Aclaris Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc. Put
BCAB / BioAtla, Inc.
LQDA / Liquidia Corporation
IGMS / IGM Biosciences, Inc.
ALGS / Aligos Therapeutics, Inc.
APTO / Aptose Biosciences Inc.
KDMN / Kadmon Holdings Inc
AGTC / Applied Genetic Technologies Corp
AKUS / Akouos Inc
ZYME / Zymeworks Inc.
XLRN / Acceleron Pharma Inc
ARNA / Arena Pharmaceuticals Inc
ETTX / Entasis Therapeutics Holdings Inc
CGEN / Compugen Ltd.
PTCT / PTC Therapeutics, Inc.
IMTX / Immatics N.V.
REPL / Replimune Group, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
BMRN / BioMarin Pharmaceutical Inc.
XLV / The Select Sector SPDR Trust - The Health Care Select Sector SPDR Fund Put
PTGX / Protagonist Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.
CMPI / Checkmate Pharmaceuticals Inc
CALA / Calithera Biosciences, Inc.
CALA / Calithera Biosciences, Inc. Put
NVCR / NovoCure Limited Call
HZNP / Horizon Therapeutics Plc
ITCI / Intra-Cellular Therapies, Inc.
RETA / Reata Pharmaceuticals Inc - Class A Put
OBSV / ObsEva SA.
JNCE / Jounce Therapeutics Inc
CHRS / Coherus Oncology, Inc.
KRTX / Karuna Therapeutics, Inc.
RGNX / REGENXBIO Inc.
CYTK / Cytokinetics, Incorporated Put
CYTK / Cytokinetics, Incorporated
BCRX / BioCryst Pharmaceuticals, Inc.
MGNX / MacroGenics, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
ABBV / AbbVie Inc.
MRK / Merck & Co., Inc.
SUPN / Supernus Pharmaceuticals, Inc.
IWM / iShares Trust - iShares Russell 2000 ETF Put
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
MRUS / Merus N.V.
UTHR / United Therapeutics Corporation
RETA / Reata Pharmaceuticals Inc - Class A
LLY / Eli Lilly and Company
GRTX / Galera Therapeutics, Inc.
RCUS / Arcus Biosciences, Inc.
NCNA / NuCana plc - Depositary Receipt (Common Stock)
JAZZ / Jazz Pharmaceuticals plc
YMAB / Y-mAbs Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
SRPT / Sarepta Therapeutics, Inc.
MRNS / Marinus Pharmaceuticals, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
SYBX / Synlogic, Inc.
TGTX / TG Therapeutics, Inc.
INSM / Insmed Incorporated
NTRA / Natera, Inc.
MRNS / Marinus Pharmaceuticals, Inc. Call
INZY / Inozyme Pharma, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)